Recombinant antibody against human cardiac troponin I
US12304947B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2019 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Oct 22, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/325
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides an isolated binding protein comprising a cTnI antigen binding domain. The antigen binding domain comprises at least one complementarity determining region selected from amino acid sequences defined herein, or has sequence identity of at least 80% to the complementarity determining region of said amino acid sequence and an affinity of KD≤1.41×10−9 mol/L to cTnI. The binding protein can be used for detection of cTnI protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.